CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(11): E1707-E1712
DOI: 10.1055/a-1244-1646
Original article

Adenoma detection rate as a quality indicator for colonoscopy: a descriptive cross-sectional study from a tertiary care hospital in Pakistan

Mian Shah Yousaf
1   Section of Gastroenterology, Department of Medicine, Aga Khan University, Karachi, Pakistan
,
Shameel Shafqat
2   Medical College, Aga Khan University, Karachi, Pakistan
,
Roger Christopher Gill
3   General Surgery, Department of Surgery, Aga Khan University, Karachi, Pakistan
,
Asfia Arham Khursheed
3   General Surgery, Department of Surgery, Aga Khan University, Karachi, Pakistan
,
Om Parkash
1   Section of Gastroenterology, Department of Medicine, Aga Khan University, Karachi, Pakistan
› Author Affiliations

Abstract

Background and study aims Adenoma detection rate (ADR) is validated for measuring quality of colonoscopy, however there is lack of colorectal cancer (CRC) screening program in South Asia. The purpose of this study is to analyze and review the polyp detection rate (PDR) and ADR and provide insight into the factors that influence them in Pakistan.

Patients and methods This retrospective, cross-sectional study was performed at the Aga Khan University Hospital, Karachi, Pakistan, on patients ≥ 18 years, who underwent colonoscopy between January 1, 2017 and June 30, 2018.

Results Of 1985 patients, 59 % were male and 41 % female, with mean age of 47.8 ± 16.2 years. The most common indication for colonoscopy was bleeding-per-rectum (28.0 %) and overall PDR and ADR were 17.9 % and 9.9 %, respectively. There was no significant difference between genders for either PDR (P = 0.378) or ADR (P = 0.574). Significantly higher PDR and ADR were found for patients ≥ 50 years (P < 0.001), as well as for suboptimal bowel preparation [PDR (25.7 %; P = 0.007) and ADR (18.6 %; P = 0.014)]. Interestingly, endoscopists with < 500 colonoscopy-procedural-experience reported a higher PDR (21.6 %; P = 0.020) and ADR (14.4 %; P = 0.049), corresponding to a significantly higher PDR (20.6 %; P = 0.005) and ADR (11.7 %; P = 0.02) for endoscopists in practice for ≤ 10 years.

Conclusions We have noticed low PDR and ADR, which require further investigation and research. In addition, we believe there should be a different baseline ADR and PDR as a quality indicator for colonoscopy in our region, where no internationally recommended colonoscopic screening programs have been implemented.



Publication History

Received: 09 March 2020

Accepted: 30 July 2020

Article published online:
22 October 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Bray F, Ferlay J, Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424
  • 2 Bretthauer M, Kalager M. Mass Medical Soc. Colonoscopy as a triage screening test. N Engl J Med 2012; 366: 759-760
  • 3 Garborg K, Holme Ø, Løberg M. et al. Current status of screening for colorectal cancer. Ann Oncol 2013; 24: 1963-1972
  • 4 Shaukat A, Mongin SJ, Geisser MS. et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106-1114
  • 5 Nishihara R, Wu K, Lochhead P. et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013; 369: 1095-1105
  • 6 Zauber AG, Winawer SJ, O'Brien MJ. et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-696
  • 7 Qaseem A, Denberg TD, Hopkins RH. et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 2012; 156: 378-386
  • 8 Rex DK, Johnson DA, Anderson JC. et al. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol 2009; 104: 739-750
  • 9 Kaminski MF, Thomas-Gibson S, Bugajski M. et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. Endoscopy 2017; 49: 378-397
  • 10 Kaminski MF, Regula J, Kraszewska E. et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795-1803
  • 11 Corley DA, Jensen CD, Marks AR. et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014; 370: 1298-1306
  • 12 Rex DK, Schoenfeld PS, Cohen J. et al. Quality indicators for colonoscopy. Gastrointest Endosc 2015; 81: 31-53
  • 13 Lai EJ, Calderwood AH, Doros G. et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc 2009; 69: 620-625
  • 14 Cooper GS, Chak A, Koroukian S. The polyp detection rate of colonoscopy: a national study of Medicare beneficiaries. Am J Med 2005; 118: 1413.e1411-1413.e1414
  • 15 Rehman KU, Qureshi MO, Khokhar N. et al. Quality of colonoscopy and spectrum of lower gastrointestinal disease as determined by colonoscopy. J Coll Physicians Surg Pak 2015; 25: 478-481
  • 16 Mohammad S, Rind GH, Shah IA. et al. Colonoscopy Findings: A Single Institution Study from Pakistan. Cureus 2019; 11: e6167
  • 17 Wolf AM, Fontham ET, Church TR. et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018; 68: 250-281
  • 18 Center for Disease Control and Prevention. Colorectal (Colon) Cancer. 2020 Available from (Accessed 2020 5th July): https://www.cdc.gov/cancer/colorectal/basic_info/screening/index.htm#:~:text=Screening%20Guidelines,if%20they%20should%20be%20screened
  • 19 Rex DK. Colonoscopy: a review of its yield for cancers and adenomas by indication. Am J Gastroenterol 1995; 90: 353-365
  • 20 Lee TJ, Rutter MD, Blanks RG. et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 2012; 61: 1050-1057
  • 21 Johnson DA, Barkun AN, Cohen LB. et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. Gastroenterology 2014; 147: 903-924
  • 22 Froehlich F, Wietlisbach V, Gonvers J-J. et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc 2005; 61: 378-384
  • 23 Adike A, Buras MR, Gurudu SR. et al. Is the level of cleanliness using segmental Boston bowel preparation scale associated with a higher adenoma detection rate?. Ann Gastroenterol 2018; 31: 217-223
  • 24 Calderwood AH, Thompson KD, Schroy PC. et al. Good is better than excellent: bowel preparation quality and adenoma detection rates. Gastrointest Endosc 2015; 81: 691-699.e691
  • 25 Anderson JC, Butterly LF, Robinson CM. et al. Impact of fair bowel preparation quality on adenoma and serrated polyp detection: data from the New Hampshire colonoscopy registry by using a standardized preparation-quality rating. Gastrointest Endosc 2014; 80: 463-470
  • 26 Pace D, Borgaonkar M, Lougheed M. et al. Effect of Colonoscopy Volume on Quality Indicators. Can J Gastroenterol and Hepatol 2016; 2016: 2580894
  • 27 Solís-Muñoz P, Solís-Herruzo JA, Rodríguez-Muñoz S. Experience of the endoscopist increases detection rates of smaller size and higher histological grade polyps. J Gastroenterol Hepatol 2014; 29: 1237-1241
  • 28 Almario CV, Spiegel BM. Does endoscopist fatigue impact adenoma detection rate? A review of the evidence to date. Gastrointest Endosc 2017; 85: 611-613
  • 29 Chan MY, Cohen H, Spiegel BM. Fewer polyps detected by colonoscopy as the day progresses at a Veteran's Administration teaching hospital. Clin Gastroenterol Hepatol 2009; 7: 1217-1223 ; quiz 1143
  • 30 Kaneshiro M, Ho A, Chan M. et al. Colonoscopy yields fewer polyps as the day progresses despite using social influence theory to reverse the trend. Gastrointest Endosc 2010; 72: 1233-1240
  • 31 Long MD, Martin C, Sandler RS. et al. Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol 2011; 45: 253-258
  • 32 Lee A, Jensen CD, Marks AR. et al. Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting. Gastrointest Endosc 2017; 85: 601-610.e602
  • 33 Gurudu SR, Ratuapli SK, Leighton JA. et al. Adenoma detection rate is not influenced by the timing of colonoscopy when performed in half-day blocks. Am J Gastroenterol 2011; 106: 1466-1471
  • 34 Adler A, Wegscheider K, Lieberman D. et al. Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12 134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut 2013; 62: 236-241
  • 35 Adler A, Aminalai A, Aschenbeck J. et al. Latest generation, wide-angle, high-definition colonoscopes increase adenoma detection rate. Clin Gastroenterol Hepatol 2012; 10: 155-159